COMPANIES COVERED
RebiotixDownload FREE Report Sample
Download Free sampleHuman microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities.
Human Microbiome Therapeutic Drugs Market contains market size and forecasts of Human Microbiome Therapeutic Drugs in Global, including the following market information:
Global Human Microbiome Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Microbiome Therapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
FMT Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Microbiome Therapeutic Drugs include Rebiotix, Seres Therapeutics, Vedanta Biosciences, Bristol-Myers Squibb, Johnson and Johnson, Takeda and ENTEROME Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Microbiome Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Microbiome Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Microbiome Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
FMT
Microbiome Drugs
Others
Global Human Microbiome Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Microbiome Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Stomach
Oral
Respiratory Tract
Others
Global Human Microbiome Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Microbiome Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Microbiome Therapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Microbiome Therapeutic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson and Johnson
Takeda
ENTEROME Bioscience
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
